Ipamorelin specifically targets growth hormone receptors, resulting in a rise in the manufacturing of insulin-like development issue 1 (IGF-1).
Ipamorelin specifically targets growth hormone receptors, resulting in a rise in the manufacturing of insulin-like development issue 1 (IGF-1).